Accordingly, ncRAN tended to be overexpressed, albeit moderately, in the cancer tissues in our study, but the association of lower expression with worse prognosis in one sample set argues against an important function of ncRAN upregulation in tumour progression. This evidence concerns the gene SNHG16 and cancer.